Protein detail

L1CAM

Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171)

Protein symbol
L1CAM
UniProt ID
EVMP score
0.50
Frequency
2
Transmembrane count
1
Protein classification
CD markersDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins
Basic Information
Protein Names
Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171)
Protein Class
CD markersDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins
Protein Function
  • Human disease related genes:Nervous system diseases:Other nervous and sensory system diseases
  • Predicted intracellular proteins
  • CD markers
  • Human disease related genes:Congenital malformations:Congenital malformations of the nervous system
  • Disease related genes
Transmembrane
1121..1143; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
CAML1CD171HSASHSAS1MASAMIC5NCAM-L1S10SPG1
Gene Description
L1 cell adhesion molecule
Chromosome
X
Position
153861514-153886173
Frequency
2
EVMP Score
0.50
Fluorescence & Localization
Tissue SpecificbrainCell SpecificBrain excitatory neuronsSingle-Nuclei Brain Specificoligodendrocyte
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

11 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
L1CAMRPS6KA1Q15418S1,152phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPSIGNORProtMapperHPRDKEASIGNOR_ProtMapperHPRD:8663493ProtMapper:8663493SIGNOR:8663493KEA:8663493
L1CAMCSNK2A1P68400S1,181phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPSIGNORProtMapperKEASIGNOR_ProtMapperPhosphoSitePhosphoSite_ProtMapperKEA:8592152ProtMapper:8592152SIGNOR:8592152
L1CAMCSNK2A1P68400S1,177phosphorylationHPRDKEAHPRD:8592152KEA:8592152HPRD:19651622HPRD:20068231HPRD:18669648HPRD:18452278
L1CAMCSNK2A1P68400T1,172phosphorylationPhosphoSite_MIMPMIMPProtMapperPhosphoSitePhosphoSite_ProtMapper
L1CAMRPS6KA2Q15349S1,152phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPSIGNORProtMapperKEASIGNOR_ProtMapperKEA:8663493ProtMapper:8663493SIGNOR:8663493
L1CAMEPHB2P29323Y1,229phosphorylationPhosphoSite
L1CAMSRCP12931Y1,176phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPProtMapperReactome_ProtMapperPhosphoSitePhosphoSite_ProtMapper
L1CAMMAPK1P28482S1,204phosphorylationPhosphoSite_MIMPMIMPHPRD_MIMPProtMapperPhosphoSitePhosphoSite_ProtMapper
L1CAMMAPK1P28482S1,248phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPProtMapperPhosphoSitePhosphoSite_ProtMapper
L1CAMPRKCAP17252T1,172phosphorylationPhosphoSite_MIMPMIMPProtMapperPhosphoSitePhosphoSite_ProtMapper
Page 1 of 2Next

Ligand-Receptor Signaling

52 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembrane_predictedtransmembraneOmniPathNoNoYesYesNo
transmembranetransmembraneGO_IntercellNoNoYesYesNo
transmembranetransmembraneCellPhoneDBNoNoYesYesNo
transmembranetransmembraneTopDBNoNoYesYesNo
transmembranetransmembraneRamilowski_locationNoNoYesYesNo
transmembranetransmembraneOmniPathNoNoYesYesNo
plasma_membraneplasma_membraneUniProt_locationNoNoYesYesNo
plasma_membraneplasma_membraneCellinkerNoNoYesYesNo
plasma_membraneplasma_membraneOmniPathNoNoYesYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneMembranomeNoNoYesYesNo
Page 3 of 6PreviousNext

Regulatory Interaction Network

7 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
KS6A1Q15418L1CAMP32004YesYesNophosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperHPRDReactome_ProtMapperPhosphoSite_KEAKEAHPRD_KEASIGNOR_ProtMapperHPRD-phosKEA:8663493SIGNOR:8663493ProtMapper:8663493HPRD:8663493HPRD-phos:8663493
CSK21P68400L1CAMP32004YesNoNoWangphosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperHPRDPhosphoSite_KEAKEAHPRD_KEASIGNOR_ProtMapperPhosphoSiteHPRD-phosPhosphoSite_ProtMapperPhosphoSite:8592152HPRD-phos:18452278ProtMapper:8592152SIGNOR:8592152HPRD:8592152HPRD-phos:8592152KEA:8592152ProtMapper:19651622ProtMapper:20068231HPRD-phos:20068231HPRD-phos:18669648PhosphoSite:17253643ProtMapper:18669648ProtMapper:18452278HPRD-phos:19651622
KPCAP17252L1CAMP32004YesNoYesPhosphoSite_MIMPMIMPiPTMnetSIGNORProtMapperPhosphoSitePhosphoSite_ProtMapperPhosphoSite:20335502SIGNOR:20335502
KS6A2Q15349L1CAMP32004YesYesNophosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPiPTMnetPhosphoPointSIGNORProtMapperHPRDReactome_ProtMapperKEAHPRD_KEASIGNOR_ProtMapperHPRD:8663493ProtMapper:8663493SIGNOR:8663493KEA:8663493
EPHB2P29323L1CAMP32004YesNoNoWangPhosphoSitePhosphoSite_ProtMapperProtMapperPhosphoSite:31640849PhosphoSite:29109170PhosphoSite:19720049
MK01P28482L1CAMP32004YesYesNophosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPPhosphoSite_norefiPTMnetProtMapperReactome_ProtMapperWangPhosphoSitePhosphoSite_ProtMapperPhosphoSite:21080252PhosphoSite:17151951
SRCP12931L1CAMP32004YesNoNophosphoELM_MIMPPhosphoSite_MIMPMIMPiPTMnetProtMapperReactome_ProtMapperPhosphoSitePhosphoSite_ProtMapperPhosphoSite:9570805PhosphoSite:9651214

Protein Complex Composition

0 records.

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Mass spectrometry0
Sequence, Structure & Domains

Sequences

Length
1,257
Mass
140,003
Sequence
MVVALRYVWPLLLCSPCLLIQIPEEYEGHHVMEPPVITEQSPRRLVVFPTDDISLKCEASGKPEVQFRWTRDGVHFKPKEELGVTVYQSPHSGSFTITGNNSNFAQRFQGIYRCFASNKLGTAMSHEIRLMAEGAPKWPKETVKPVEVEEGESVVLPCNPPPSAEPLRIYWMNSKILHIKQDERVTMGQNGNLYFANVLTSDNHSDYICHAHFPGTRTIIQKEPIDLRVKATNSMIDRKPRLLFPTNSSSHLVALQGQPLVLECIAEGFPTPTIKWLRPSGPMPADRVTYQNHNKTLQLLKVGEEDDGEYRCLAENSLGSARHAYYVTVEAAPYWLHKPQSHLYGPGETARLDCQVQGRPQPEVTWRINGIPVEELAKDQKYRIQRGALILSNVQPSDTMVTQCEARNRHGLLLANAYIYVVQLPAKILTADNQTYMAVQGSTAYLLCKAFGAPVPSVQWLDEDGTTVLQDERFFPYANGTLGIRDLQANDTGRYFCLAANDQNNVTIMANLKVKDATQITQGPRSTIEKKGSRVTFTCQASFDPSLQPSITWRGDGRDLQELGDSDKYFIEDGRLVIHSLDYSDQGNYSCVASTELDVVESRAQLLVVGSPGPVPRLVLSDLHLLTQSQVRVSWSPAEDHNAPIEKYDIEFEDKEMAPEKWYSLGKVPGNQTSTTLKLSPYVHYTFRVTAINKYGPGEPSPVSETVVTPEAAPEKNPVDVKGEGNETTNMVITWKPLRWMDWNAPQVQYRVQWRPQGTRGPWQEQIVSDPFLVVSNTSTFVPYEIKVQAVNSQGKGPEPQVTIGYSGEDYPQAIPELEGIEILNSSAVLVKWRPVDLAQVKGHLRGYNVTYWREGSQRKHSKRHIHKDHVVVPANTTSVILSGLRPYSSYHLEVQAFNGRGSGPASEFTFSTPEGVPGHPEALHLECQSNTSLLLRWQPPLSHNGVLTGYVLSYHPLDEGGKGQLSFNLRDPELRTHNLTDLSPHLRYRFQLQATTKEGPGEAIVREGGTMALSGISDFGNISATAGENYSVVSWVPKEGQCNFRFHILFKALGEEKGGASLSPQYVSYNQSSYTQWDLQPDTDYEIHLFKERMFRHQMAVKTNGTGRVRLPPAGFATEGWFIGFVSAIILLLLVLLILCFIKRSKGGKYSVKDKEDTQVDSEARPMKDETFGEYRSLESDNEEKAFGSSQPSLNGDIKPLGSDDSLADYGGSVDVQFNEDGSFIGQYSGKKEKEAAGGNDSSGATSPINPAVALE
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=P32004-1; Sequence=Displayed; Name=2; IsoId=P32004-2; Sequence=VSP_002591; Name=3; IsoId=P32004-3; Sequence=VSP_046317, VSP_002591
Alternative Sequence
26..31; YEGHHV -> L (in isoform 3); 1177..1180; Missing (in isoform 2 and isoform 3)

3D Structural Models

Turn
757..759
Helix
740..742; 838..840
Beta Strand
722..724; 730..734; 744..746; 749..756; 764..777; 783..792; 803..806; 818..825; 828..833; 847..856; 869..874; 879..882; 890..898; 907..912
3D Structure
X-ray crystallography (2)

Domain & Motif Annotations

Compositional Bias
713..725; Basic and acidic residues; 1176..1187; Basic and acidic residues; 1241..1250; Polar residues
Motif
554..556; Cell attachment site
Domain (FT)
35..125; Ig-like C2-type 1; 139..226; Ig-like C2-type 2; 240..328; Ig-like C2-type 3; 333..420; Ig-like C2-type 4; 425..507; Ig-like C2-type 5; 518..607; Ig-like C2-type 6; 615..712; Fibronectin type-III 1; 717..810; Fibronectin type-III 2; 814..916; Fibronectin type-III 3; 920..1015; Fibronectin type-III 4; 1016..1115; Fibronectin type-III 5
Region
698..725; Disordered; 1176..1207; Disordered; 1226..1257; Disordered
Protein Families
  • Immunoglobulin superfamily
  • L1/neurofascin/NgCAM family
Sequence Similarities
Belongs to the immunoglobulin superfamily. L1/neurofascin/NgCAM family.
Clinical Relevance
Disease Involvement
Disease variantHereditary spastic paraplegiaHirschsprung diseaseIntellectual disabilityNeurodegeneration
Biomarker
Phase 1
Drugs
Antibody